Fig. 2From: Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinibEstimated relationships between PASDAS and FACIT-F total score (a), Pain VAS (b), and HAQ-DI (c). Data from OPAL Broaden (N = 422) and OPAL Beyond (N = 394); all treatment groups from each phase 3 study were pooled for analysis. Arrows indicate the direction of improvement. FACIT-F, Functional Assessment of Chronic Illness Therapy-Fatigue; HAQ-DI, Health Assessment Questionnaire-Disability Index; Pain VAS, Patient’s Assessment of Arthritis Pain visual analog scale; PASDAS, Psoriatic Arthritis Disease Activity Score; VAS visual analog scaleBack to article page